Evolus (EOLS) Total Debt (2017 - 2026)
Evolus (EOLS) posted Total Debt of $156.4 million for Q1 2026, up 7.06% on a QoQ basis from $146.1 million in Q4 2025, and up 28.41% year-over-year from $121.8 million in Q1 2025.
Evolus (EOLS) Total Debt (2017 - 2026) Analysis & Trends
Evolus' Total Debt history runs 10 years deep, the most recent figure standing at $156.4 million for Q1 2026.
- Quarterly Total Debt rose 28.41% year-over-year to $156.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $156.4 million (up 28.41% YoY) and the FY2025 annual result came in at $146.1 million, up 20.24% from the prior year.
- Total Debt was $156.4 million for Q1 2026 at Evolus, up from $146.1 million in the prior quarter.
- Across five years, Total Debt topped out at $156.4 million in Q1 2026 and bottomed at $71.4 million in Q1 2022.
- A 5-year average of $109.9 million and a median of $120.6 million in 2024 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2022 — Total Debt increased 0.92% — and 2023, when it soared 67.45%.
- Evolus' Total Debt stood at $71.9 million in 2022, then jumped by 67.45% to $120.4 million in 2023, then rose by 0.95% to $121.5 million in 2024, then advanced by 20.24% to $146.1 million in 2025, then gained by 7.06% to $156.4 million in 2026.
- Business Quant data shows EOLS's Total Debt at $156.4 million in Q1 2026, $146.1 million in Q4 2025, and $145.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | 156.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156.41 Mn |
| Dec 31, 2025 | 146.10 Mn |
| Sep 30, 2025 | 145.78 Mn |
| Jun 30, 2025 | 145.48 Mn |
| Mar 31, 2025 | 121.81 Mn |
| Dec 31, 2024 | 121.51 Mn |
| Sep 30, 2024 | 121.21 Mn |
| Jun 30, 2024 | 120.92 Mn |
| Mar 31, 2024 | 120.64 Mn |
| Dec 31, 2023 | 120.36 Mn |
| Sep 30, 2023 | 95.09 Mn |
| Jun 30, 2023 | 94.83 Mn |
| Mar 31, 2023 | 72.05 Mn |
| Dec 31, 2022 | 71.88 Mn |
| Sep 30, 2022 | 71.71 Mn |
| Jun 30, 2022 | 71.55 Mn |
| Mar 31, 2022 | 71.38 Mn |
| Dec 31, 2021 | 71.22 Mn |
| Dec 31, 2020 | 74.38 Mn |
| Sep 30, 2020 | 73.97 Mn |